Response to: reassessing formulary changes
We thank Drs Mistry and Nair for their interest in our recent publication examining the implications of removing liposomal bupivacaine from an academic hospital formulary.[1 2][1] Their five itemized comments can be reasonably distilled into two overarching themes. First, they highlight the inherent
Authors
- Brian D. Sites (ORCID: https://orcid.org/0000-0002-5104-8499)
- Yvon F. Bryan
- Gerard Kerins
- M. K. Davis
- Timothy M. Millington
- Anuj B Patel
Institutions
- Dartmouth College (US)
- Dartmouth–Hitchcock Medical Center (US)
- University of Michigan (US)
- Dartmouth Psychiatric Research Center (US)
- Dartmouth Health (US)
Publication Details
- Journal
- Regional Anesthesia & Pain Medicine
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1136/rapm-2025-107529
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00